Vivani Medical, Inc.

NasdaqCM:VANI Stock Report

Market Cap: US$68.7m

Vivani Medical Future Growth

Future criteria checks 0/6

Vivani Medical's earnings are forecast to decline at 10.5% per annum. EPS is expected to decline by 6.1% per annum.

Key information

-10.5%

Earnings growth rate

-6.1%

EPS growth rate

Medical Equipment earnings growth16.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated20 Dec 2024

Recent future growth updates

No updates

Recent updates

We Think Vivani Medical (NASDAQ:VANI) Needs To Drive Business Growth Carefully

Aug 19
We Think Vivani Medical (NASDAQ:VANI) Needs To Drive Business Growth Carefully

Is Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth?

Dec 23
Is Vivani Medical (NASDAQ:VANI) In A Good Position To Invest In Growth?

Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation

Jul 13
Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation

Companies Like Vivani Medical (NASDAQ:VANI) Are In A Position To Invest In Growth

Apr 07
Companies Like Vivani Medical (NASDAQ:VANI) Are In A Position To Invest In Growth

We Think Vivani Medical (NASDAQ:VANI) Can Afford To Drive Business Growth

Dec 06
We Think Vivani Medical (NASDAQ:VANI) Can Afford To Drive Business Growth

Earnings and Revenue Growth Forecasts

NasdaqCM:VANI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026N/A-32N/AN/A1
12/31/2025N/A-26N/A-222
12/31/2024N/A-24N/A-192
9/30/2024N/A-23-19-18N/A
6/30/2024N/A-24-22-20N/A
3/31/2024N/A-25-22-21N/A
12/31/2023N/A-26-25-24N/A
9/30/2023N/A-27-26-25N/A
6/30/2023N/A-19-25-25N/A
3/31/2023N/A-16-23-23N/A
12/31/2022N/A-14-19-19N/A
9/30/2022N/A-10-17-17N/A
6/30/2022N/A-15-13-13N/A
3/31/2022N/A-14-12-12N/A
12/31/2021N/A-13-12-11N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VANI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: VANI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: VANI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if VANI's revenue is forecast to grow faster than the US market.

High Growth Revenue: VANI is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if VANI's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 19:06
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vivani Medical, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yi ChenH.C. Wainwright & Co.
Nazibur RahmanMaxim Group
Ashok KumarThinkEquity LLC